Renaissance Technologies
AYTU icon

Renaissance Technologies’s AYTU BioPharma AYTU Stock Holding History

Renaissance Technologies’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256K Buy
93,723
+4,100
+5% +$10.5K ﹤0.01% 2856
2025
Q4 		$233K Sell
89,623
-5,500
-6% -$12.3K ﹤0.01% 2848
2025
Q3 		$179K Buy
95,123
+5,210
+6% +$12K ﹤0.01% 3150
2025
Q2 		$196K Buy
89,913
+13,090
+17% +$20.3K ﹤0.01% 3175
2025
Q1 		$92.2K Buy
76,823
+1,400
+2% +$2.04K ﹤0.01% 3210
2024
Q4 		$128K Buy
75,423
+700
+0.9% +$1.28K ﹤0.01% 3247
2024
Q3 		$176K Buy
74,723
+600
+0.8% +$1.55K ﹤0.01% 3151
2024
Q2 		$216K Buy
74,123
+2,800
+4% +$8.45K ﹤0.01% 3022
2024
Q1 		$217K Buy
71,323
+2,400
+3% +$6.87K ﹤0.01% 3201
2023
Q4 		$196K Buy
68,923
+8,200
+14% +$22.6K ﹤0.01% 3139
2023
Q3 		$164K Buy
60,723
+3,400
+6% +$5.95K ﹤0.01% 3134
2023
Q2 		$92K Buy
57,323
+7,700
+16% +$15.1K ﹤0.01% 3495
2023
Q1 		$111K Sell
49,623
-57,416
-54% -$168K ﹤0.01% 3458
2022
Q4 		$405K Buy
107,039
+19,663
+23% +$74K ﹤0.01% 3066
2022
Q3 		$323K Buy
87,376
+34,587
+66% +$262K ﹤0.01% 3182
2022
Q2 		$728K Buy
52,789
+14,516
+38% +$186K ﹤0.01% 2911
2022
Q1 		$827K Buy
38,273
+5,020
+15% +$125K ﹤0.01% 2854
2021
Q4 		$898K Buy
33,253
+223
+0.7% +$9.64K ﹤0.01% 2726
2021
Q3 		$1.9M Buy
33,030
+9,162
+38% +$688K ﹤0.01% 2129
2021
Q2 		$2.39M Buy
23,868
+17,342
+266% +$2.03M ﹤0.01% 2141
2021
Q1 		$992K Buy
+6,526
New +$1.04M ﹤0.01% 2611
2020
Q3 		– Sell
-330
Closed -$94K – 3369
2020
Q2 		$94K Sell
330
-1,198
-78% -$363K ﹤0.01% 3288
2020
Q1 		$458K Buy
+1,528
New +$295K ﹤0.01% 2799
2019
Q1 		– Sell
-476
Closed -$75K – 3445
2018
Q4 		$75K Buy
476
+393
+473% +$86.6K ﹤0.01% 3260
2018
Q3 		$46K Buy
+83
New +$76.8K ﹤0.01% 3288

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies's AYTU Position: Q1 2026 in Review

Renaissance Technologies increased its AYTU BioPharma (AYTU) stake by 4.6% in Q1 2026, buying an estimated $10.5K and bringing the position to 93,723 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Renaissance Technologies first reported a position in AYTU in Q3 2018 and has held it in 25 quarters since. The position peaked at $2.39M in Q2 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Renaissance Technologies held 93,723 shares of AYTU BioPharma worth $256K as of Q1 2026.
  • Renaissance Technologies bought 4,100 AYTU BioPharma shares in Q1 2026, an estimated $10.5K.
  • AYTU BioPharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2856 holding.
  • Renaissance Technologies first reported a position in AYTU BioPharma in Q3 2018 and has held it in 25 quarters since.
  • Renaissance Technologies's AYTU BioPharma position peaked at $2.39M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.